23 results
Insulin Analogs - Short, Intermediate and Long Acting - Onset, Peak, Duration

#Diabetes #Insulin #Analogs #Onset #Duration
Insulin Analogs - Short ... - Onset, Peak, Duration ... Analogs #Onset #Duration ... Peaks #Comparison #Pharmacology ... #Endocrinology
Insulin Pharmacology and Conversion

 • Conversion of U-100 to U-500 Insulin
 • Inpatient Intravenous to subcutaneous
Insulin Pharmacology ... Action: Rapid, Short ... DharSaty #Insulin #Pharmacology ... #Conversion #Duration ... timeline #halflife #endocrinology
Insulin Comparison Chart

Insulin Types - Onset (hours) - Peak Glycemic Effect (hours) - Duration (hours)
 •
Effect (hours) - Duration ... ), Afrezza • Short-Acting ... Insulin #Comparison #Table ... #pharmacology # ... diabetes #endocrinology
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
abstinent from short-acting ... margin of safety in pharmacology ... the sublingual tablet ... Pharmacokinetics #Comparison #Table ... #Pharmacology #
Stepwise approach for managing asthma in youths greater than 12 years of age and adults as
National Asthma Education ... β2-agonists or ... receive education ... long-acting β2-agonists ... β2-agonists).
Summary of actions of some Cholinergic Agonists

Bethanechol 
• Used in treatment of urinary retention 
• Binds
some Cholinergic Agonists ... blockers • Has short ... #Cholinergic #Agonists ... #Pharmacology # ... Table #Summary
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... Ozempic), or daily tablet ... #Pharmacology # ... DM2 #diabetes #endocrinology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Januvia) - Once/day tablet ... GLP-I receptor agonist ... DPP4 #Inhibitors #Pharmacology ... DM2 #diabetes #endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
risks, and therapy should ... #pharmacology #pharmacotherapy ... #table #comparison ... medications #diabetes #endocrinology
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GLP-1 Agonists ... Daily GLP-1 Agonists ... of my previous posts ... #Pharmacology #Dosing ... Diabetes #DM2 #Endocrinology